AI Breakthrough for Lung Disease: Thirona’s LungQ Receives FDA Clearance

HIT Consultant January 23, 2024
Jasmine Pennic

What You Should Know:

– Thirona, a pioneer in AI-powered lung analysis, received a major boost for its cutting-edge technology LungQ™ with the U.S. Food and Drug Administration (FDA) 510(k) clearance for its latest update, v3.0.0.

– This FDA clearance paves the way for American hospitals to now harness the software’s advanced capabilities, marking a significant step forward in lung disease diagnosis and treatment.

LungQ 3.0.0: Precision Navigation for Lung Interventions

This latest iteration stands out as one of the few FDA-cleared solutions capable of automatically segmenting and analyzing the intricate landscape of the lungs’ internal anatomy. Its AI prowess goes beyond mere mapping; it identifies key structures like lobes, segments, subsegments, airways, and fissures, allowing for:

• Detailed tissue...

Today's Sponsors

Today's Sponsor